The Bluetongue Disabled Infectious Single Animal (DISA) Vaccine Platform Based on Deletion NS3/NS3a Protein Is Safe and Protective in Cattle and Enables DIVA
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Bluetongue Disabled Infectious Single Animal (DISA) Vaccine Platform Based on Deletion NS3/NS3a Protein Is Safe and Protective in Cattle and Enables DIVA
Authors
Keywords
-
Journal
Viruses-Basel
Volume 13, Issue 5, Pages 857
Publisher
MDPI AG
Online
2021-05-08
DOI
10.3390/v13050857
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Within-farm transmission characteristics of bluetongue virus serotype 8 in cattle and sheep in the Netherlands, 2007-2008
- (2021) Thomas J. Hagenaars et al. PLoS One
- Putative Novel Serotypes ‘33’ and ‘35’ in Clinically Healthy Small Ruminants in Mongolia Expand the Group of Atypical BTV
- (2020) Christina Ries et al. Viruses-Basel
- Novel Function of Bluetongue Virus NS3 Protein in Regulation of the MAPK/ERK Signaling Pathway
- (2019) Cindy Kundlacz et al. JOURNAL OF VIROLOGY
- Characterization of bluetongue virus serotype 28
- (2019) Velizar Bumbarov et al. Transboundary and Emerging Diseases
- Virus‐induced autophagic degradation of STAT 2 as a mechanism for interferon signaling blockade
- (2019) Miguel Avia et al. EMBO REPORTS
- Vector competence is strongly affected by a small deletion or point mutations in bluetongue virus
- (2019) René G. P. van Gennip et al. Parasites & Vectors
- Prospects of Next-Generation Vaccines for Bluetongue
- (2019) Piet A. van Rijn Frontiers in Veterinary Science
- One after the other: A novel Bluetongue virus strain related to Toggenburg virus detected in the Piedmont region (North-western Italy), extends the panel of novel atypical BTV strains
- (2018) Maurilia Marcacci et al. Transboundary and Emerging Diseases
- Diagnostic DIVA tests accompanying the Disabled Infectious Single Animal (DISA) vaccine platform for African horse sickness
- (2018) Piet A. van Rijn et al. VACCINE
- African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform
- (2018) Piet A. van Rijn et al. VACCINE
- Novel putative Bluetongue virus in healthy goats from Sardinia, Italy
- (2017) Giovanni Savini et al. INFECTION GENETICS AND EVOLUTION
- Bluetongue virus serotype 27: Experimental infection of goats, sheep and cattle with three BTV-27 variants reveal atypical characteristics and likely direct contact transmission BTV-27 between goats
- (2017) E. Bréard et al. Transboundary and Emerging Diseases
- Bluetongue Disabled Infectious Single Animal (DISA) vaccine: Studies on the optimal route and dose in sheep
- (2017) Piet A. van Rijn et al. VACCINE
- Current and next-generation bluetongue vaccines: Requirements, strategies, and prospects for different field situations
- (2016) Femke Feenstra et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus Vaccines
- (2016) Cristina C. Celma et al. JOURNAL OF VIROLOGY
- Emergence of a Novel Bluetongue Virus Serotype, China 2014
- (2016) E. C. Sun et al. Transboundary and Emerging Diseases
- Requirements and comparative analysis of reverse genetics for bluetongue virus (BTV) and African horse sickness virus (AHSV)
- (2016) Piet A. van Rijn et al. Virology Journal
- Characterization of a second open reading frame in genome segment 10 of bluetongue virus
- (2015) Meredith Stewart et al. JOURNAL OF GENERAL VIROLOGY
- Non-structural protein NS3/NS3a is required for propagation of bluetongue virus in Culicoides sonorensis
- (2015) Femke Feenstra et al. Parasites & Vectors
- Development of a competitive ELISA for NS3 antibodies as DIVA test accompanying the novel Disabled Infectious Single Animal (DISA) vaccine for Bluetongue
- (2015) Mirriam G.J. Tacken et al. VACCINE
- Application of Bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2
- (2015) Femke Feenstra et al. VACCINE
- Bluetongue virus without NS3/NS3a expression is not virulent and protects against virulent bluetongue virus challenge
- (2014) F. Feenstra et al. JOURNAL OF GENERAL VIROLOGY
- A Synthetic Biology Approach for a Vaccine Platform against Known and Newly Emerging Serotypes of Bluetongue Virus
- (2014) S. F. Nunes et al. JOURNAL OF VIROLOGY
- Bluetongue Virus Nonstructural Protein NS3/NS3a Is Not Essential for Virus Replication
- (2014) René G. P. van Gennip et al. PLoS One
- Cost assessment of the movement restriction policy in France during the 2006 bluetongue virus episode (BTV-8)
- (2014) Damian Tago et al. PREVENTIVE VETERINARY MEDICINE
- VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA
- (2014) Femke Feenstra et al. VACCINE
- Rapid Generation of Replication-Deficient Monovalent and Multivalent Vaccines for Bluetongue Virus: Protection against Virulent Virus Challenge in Cattle and Sheep
- (2013) C. C. P. Celma et al. JOURNAL OF VIROLOGY
- Bluetongue Virus RNA Detection by Real-Time RT-PCR in Post-Vaccination Samples from Cattle
- (2013) I. De Leeuw et al. Transboundary and Emerging Diseases
- Bluetongue virus with mutated genome segment 10 to differentiate infected from vaccinated animals: A genetic DIVA approach
- (2013) P.A. van Rijn et al. VACCINE
- Induction and control of the type I interferon pathway by Bluetongue virus
- (2013) Damien Vitour et al. VIRUS RESEARCH
- Sustained high-throughput polymerase chain reaction diagnostics during the European epidemic of Bluetongue virus serotype 8
- (2012) Piet A. van Rijn et al. JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION
- Rescue of Recent Virulent and Avirulent Field Strains of Bluetongue Virus by Reverse Genetics
- (2012) René G. P. van Gennip et al. PLoS One
- Bluetongue Viruses Based on Modified-Live Vaccine Serotype 6 with Exchanged Outer Shell Proteins Confer Full Protection in Sheep against Virulent BTV8
- (2012) René G. P. van Gennip et al. PLoS One
- Bluetongue virus serotype 6 in Europe in 2008—Emergence and disappearance of an unexpected non-virulent BTV
- (2012) Piet A. van Rijn et al. VETERINARY MICROBIOLOGY
- Bluetongue virus serotype 26: Infection kinetics, pathogenesis and possible contact transmission in goats
- (2012) C.A. Batten et al. VETERINARY MICROBIOLOGY
- Detection of a Fourth Orbivirus Non-Structural Protein
- (2011) Mourad Belhouchet et al. PLoS One
- Bluetongue: History, global epidemiology, and pathogenesis
- (2011) N. James Maclachlan PREVENTIVE VETERINARY MEDICINE
- Identification and Characterization of a Novel Non-Structural Protein of Bluetongue Virus
- (2011) Maxime Ratinier et al. PLoS Pathogens
- Full Genome Characterisation of Bluetongue Virus Serotype 6 from the Netherlands 2008 and Comparison to Other Field and Vaccine Strains
- (2010) Sushila Maan et al. PLoS One
- Occurrence and spatial distribution of Toggenburg Orbivirus in Switzerland
- (2010) Valérie Chaignat et al. SMALL RUMINANT RESEARCH
- Bluetongue virus RNA detection by RT-qPCR in blood samples of sheep vaccinated with a commercially available inactivated BTV-8 vaccine
- (2010) Adolf Steinrigl et al. VACCINE
- The Pathology and Pathogenesis of Bluetongue
- (2009) N.J. Maclachlan et al. JOURNAL OF COMPARATIVE PATHOLOGY
- A Viral Nonstructural Protein Regulates Bluetongue Virus Trafficking and Release
- (2009) C. C. P. Celma et al. JOURNAL OF VIROLOGY
- Financial consequences of the Dutch bluetongue serotype 8 epidemics of 2006 and 2007
- (2009) A.G.J. Velthuis et al. PREVENTIVE VETERINARY MEDICINE
- A DIVA system based on the detection of antibodies to non-structural protein 3 (NS3) of bluetongue virus
- (2009) Sílvia C. Barros et al. VETERINARY MICROBIOLOGY
- Experimental Reproduction of Severe Bluetongue in Sheep
- (2008) N. J. Maclachlan et al. VETERINARY PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation